Top compounds associated with response to SIRT2

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.14	0.0001
mRNA	BAY 61-3606	GDSC1000	pan-cancer	AAC	-0.13	0.0002
mRNA	Tipifarnib	GDSC1000	pan-cancer	AAC	-0.13	0.0002
mRNA	Gemcitabine	gCSI	pan-cancer	AAC	-0.2	0.0002
mRNA	Doxorubicin	gCSI	pan-cancer	AAC	-0.19	0.0002
mRNA	Irinotecan	gCSI	pan-cancer	AAC	-0.19	0.0002
mRNA	navitoclax:piperlongumine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.13	0.0002
mRNA	UNC0321	CTRPv2	pan-cancer	AAC	0.14	0.0003
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.11	0.0003
mRNA	navitoclax:birinapant (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.13	0.0004

Download CSV